Article

Two styles of acupuncture for treating painful diabetic neuropathy--a pilot randomised control trial.

Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Acupuncture in Medicine (Impact Factor: 1.68). 07/2007; 25(1-2):11-7. DOI: 10.1136/aim.25.1-2.11
Source: PubMed

ABSTRACT In a pilot study, we evaluated the clinical and mechanistic effects of two styles of acupuncture, Traditional Chinese Medicine (TCM) and Japanese acupuncture, for the treatment of painful diabetic neuropathy. Out of seven patients enrolled, three received Traditional Chinese acupuncture while four received Japanese style acupuncture. Treatments were delivered once a week for 10 weeks. Acupuncturists were permitted to select the needle interventions. Substantial differences in diagnostic techniques, choice of acupuncture points, and needle manipulation were observed between TCM and Japanese acupuncturists. Clinically, patients allocated to Japanese acupuncture reported decreased neuropathy-associated pain according to the daily pain severity score, while the group allocated to the TCM acupuncture reported minimal effects. Both acupuncture styles, however, lowered pain according to the McGill Short Form Pain Score. The TCM style improved nerve sensation according to quantitative sensory testing while the Japanese style had a more equivocal effect. No evident changes were observed in glucose control or heart rate variability in either group.

Download full-text

Full-text

Available from: Andrew C Ahn, Jul 23, 2014
0 Followers
 · 
207 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traditional Chinese Medicine (TCM) was reimbursed by the statutory health insurance in Switzerland ("Obligatorische Krankenpflegeversicherung" (OKP)) between 2000 and 2005. A project was set up specifically to evaluate TCM, as well as other 4 systems and methods of complementary medical care from a scientifically sound perspective. The decision to stop granting these 5 systems of complementary medical care OKP reimbursement at the end of the evaluation period after 2005 was not based on scientific facts but was at least in parts politically motivated. After the referendum decision in favour of anchoring "the duty to consider complementary medical care approaches" in the constitution, a new application for automatic reimbursement is being submitted based on new data. TCM is to be applied exclusively by specially trained and certified doctors ("certificate of special ability in acupuncture and TCM") if warranted by the indication, the resulting costs are to be reimbursed by the OKP. Any indication covering the whole spectrum of medicine may warrant TCM treatment if treatment by conventional medical practice is not absolutely necessary. This explicitly excludes diseases which have been proven to respond most efficiently to conventional treatment or where conventional medical treatment is needed to prevent damage for the patient. For many diseases, Western medicine is not able to either supply any treatment which is able to deal with the causes of the disease, or to supply any treatment which leads to a satisfactory measure of healing or improvement in the patient's suffering. The symptomatic pharmacological treatment used by western medicine in this context is often not well tolerated by the patient or leads to side effects with complications. Many acute or chronically relapsing infections do not necessarily require an antibiotic treatment. Considering the global threat of resistance, this is even to be avoided wherever possible. Due to the different paradigm employed, TCM is often able to offer successful treatment from its perspective for many diseases.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study is to conduct a basic analysis of the effectiveness and safety of electroacupuncture in the treatment of painful diabetic neuropathy (PDN) as compared to placebo and usual care and to evaluate the feasibility of large-scale clinical research.Methods/designThis study is a protocol for a three-armed, randomized, patient-assessor-blinded (to the type of treatment), controlled pilot trial. Forty-five participants with a >= six month history of PDN and a mean weekly pain score of >= 4 on the 11-point Pain Intensity Numerical Rating Scale (PI-NRS) will be assigned to the electroacupuncture group (n = 15), sham group (n = 15) or usual care group (n = 15). The participants assigned to the electroacupuncture group will receive electroacupuncture (remaining for 30 minutes with a mixed current of 2 Hz/120 Hz and 80% of the bearable intensity) at 12 standard acupuncture points (bilateral ST36, GB39, SP9, SP6, LR3 and GB41) twice per week for eight weeks (a total of 16 sessions) as well as the usual care. The participants in the sham group will receive sham electroacupuncture (no electrical current will be passed to the needle, but the light will be seen, and the sound of the pulse generator will be heard by the participants) at non-acupuncture points as well as the usual care. The participants in the usual care group will not receive electroacupuncture treatment during the study period and will receive only the usual care. The follow-up will be in the 5th, 9th and 17th weeks after random allocation. The PI-NRS score assessed at the ninth week will be the primary outcome measurement used in this study. The Short-Form McGill Pain Questionnaire (SF-MPQ), a sleep disturbance score (11-point Likert scale), the Short-Form 36v2 Health Survey (SF-36), the Beck Depression Inventory (BDI) and the Patient Global Impression of Change (PGIC) will be used as outcome variables to evaluate the effectiveness of the acupuncture. Safety will be assessed at every visit. The result of this trial will provide a basis for the effectiveness and safety of electroacupuncture for PDN.Trial registrationClinical Research information Service. Unique identifier: KCT0000466.
    Trials 07/2013; 14(1):225. DOI:10.1186/1745-6215-14-225 · 2.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The anti-allodynic effect of NMDA receptor antagonist and acupuncture treatments were explored through spinal p35 regulation of diabetic neuropathic rat. We evaluated the change over time of p35/p25 protein levels in the spinal cord compared with behavioral responses to thermal and mechanical stimulation in streptozotocin (STZ)-induced diabetic rats. Additionally, we studied p35 expression when electroacupuncture (EA) and a sub-effective dose of NMDA (N-methyl-D-aspartate) receptor antagonist (MK-801) were used to treat hyperalgesia in the diabetic neuropathic pain (DNP). Thermal paw withdrawal latency (PWL) and mechanical paw withdrawal threshold (PWT) were significantly decreased in the early stage of diabetes in rats. p35 expression after STZ injection gradually decreased from 1 week to 4 weeks compared to normal controls. p25 expression in 4-week diabetic rats was significantly higher than that of 2-week diabetic rats, and thermal PWL in 4-week diabetic rats showed delayed responses to painful thermal stimulation compared with those at 2 weeks. EA applied to the SP-9 point (2 Hz frequency) significantly prevented the thermal and mechanical hyperalgesia in the DNP rat. Additionally, EA combined with MK-801 prolonged anti-hyperalgesia, increased p35 expression, and decreased the cleavage of p35 to p25 during diabetic neuropathic pain. In this study we show EA combined with a sub-effective dose of MK-801 treatment in DNP induced by STZ that is related to p35/p25 expression in spinal cord.
    09/2011; 20(3):144-52. DOI:10.5607/en.2011.20.3.144